Can a new antibody tame the Body's allergic alarm system?
NCT ID NCT07757659
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental drug called XKH001 in healthy Caucasian adults. The drug is an antibody designed to block a protein involved in allergic and inflammatory responses. The study aims to see how the body processes the drug, whether it is safe and well-tolerated, and how it compares to earlier results in Chinese participants. It is a small, placebo-controlled study, meaning some participants will receive the drug and others will receive an inactive injection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- XKH001, an experimental antibody that targets a protein called IL-25, given as an injection
- What this could lead to
- If successful, this could support the development of XKH001 as a potential treatment for conditions involving IL-25, such as allergic or inflammatory diseases.
- What could go wrong
- This is a very early, small study focused on safety and drug processing, not on treating any disease. The drug may not prove effective or safe in later, larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Q-Pharm Pty Limited (also known as Nucleus Network Brisbane)
Melbourne, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fingerprint sweat could replace oral swabs for drug testing
- Wearable tech puts hormone health to the test
- Can a better hazmat suit keep first responders safer and more effective?
- Home video tracking may expose the gap between clinic walking and real-world walking after stroke
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Hamstring showdown: eccentric lifts vs sprinting for muscle gains